McKESSON CORPORATIONMcKesson Corp • March 8th, 2013 • Wholesale-drugs, proprietaries & druggists' sundries • New York
Introductory. McKesson Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I (the “Underwriters”), acting severally and not jointly, the respective amounts set forth in such Schedule I of $500,000,000 aggregate principal amount of the Company’s 1.400% Notes due 2018 (the “2018 Notes”) and $400,000,000 aggregate principal amount of the Company’s 2.850% Notes due 2023 (the “2023 Notes” and, together with the 2018 Notes, the “Notes”). J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Notes.
